Literature DB >> 10791990

Regulatable systems: applications in gene therapy and replicating viruses.

S Agha-Mohammadi1, M T Lotze.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10791990      PMCID： PMC315455          DOI： 10.1172/JCI10027

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  43 in total

Review 1.  Replication-selective adenoviruses as oncolytic agents.

Authors:  C Heise; D H Kirn
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 2.  Immunomodulation of cancer: potential use of selectively replicating agents.

Authors:  S Agha-Mohammadi; M T Lotze
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

3.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

4.  Adeno-retroviral chimeric viruses as in vivo transducing agents.

Authors:  N J Caplen; J N Higginbotham; J R Scheel; N Vahanian; Y Yoshida; H Hamada; R M Blaese; W J Ramsey
Journal:  Gene Ther       Date:  1999-03       Impact factor: 5.250

5.  Cancer vaccines: the interleukin 2 dosage effect.

Authors:  W Schmidt; T Schweighoffer; E Herbst; G Maass; M Berger; F Schilcher; G Schaffner; M L Birnstiel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

6.  Tetracycline-regulated cardiac gene expression in vivo.

Authors:  G I Fishman; M L Kaplan; P M Buttrick
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

7.  Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Authors:  G Dranoff; E Jaffee; A Lazenby; P Golumbek; H Levitsky; K Brose; V Jackson; H Hamada; D Pardoll; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Tetracycline-reversible silencing of eukaryotic promoters.

Authors:  U Deuschle; W K Meyer; H J Thiesen
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

9.  Transcriptional activation by tetracyclines in mammalian cells.

Authors:  M Gossen; S Freundlieb; G Bender; G Müller; W Hillen; H Bujard
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

10.  Tetracycline repressor-regulated gene repression in recombinant human cytomegalovirus.

Authors:  H J Kim; C Gatz; W Hillen; T R Jones
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103
View more
  16 in total

Review 1.  Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer.

Authors:  T Hermiston
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 2.  Immunomodulation of cancer: potential use of selectively replicating agents.

Authors:  S Agha-Mohammadi; M T Lotze
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

3.  Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference.

Authors:  Maciej Wiznerowicz; Didier Trono
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 4.  Cardiac gene therapy with SERCA2a: from bench to bedside.

Authors:  Judith K Gwathmey; Alexan I Yerevanian; Roger J Hajjar
Journal:  J Mol Cell Cardiol       Date:  2010-11-18       Impact factor: 5.000

Review 5.  Molecular engineering of viral gene delivery vehicles.

Authors:  David V Schaffer; James T Koerber; Kwang-il Lim
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

6.  Efficient transduction of cytotoxic and anti-HIV-1 genes by a gene-regulatable lentiviral vector.

Authors:  Yasuhiko Shinoda; Kuniko Hieda; Yoshio Koyanagi; Youichi Suzuki
Journal:  Virus Genes       Date:  2009-10       Impact factor: 2.332

7.  Regulating the expression of therapeutic transgenes by controlled intake of dietary essential amino acids.

Authors:  Cédric Chaveroux; Alain Bruhat; Valérie Carraro; Céline Jousse; Julien Averous; Anne-Catherine Maurin; Laurent Parry; Florent Mesclon; Yuki Muranishi; Pierre Cordelier; Aline Meulle; Patrick Baril; Anh Do Thi; Philippe Ravassard; Jacques Mallet; Pierre Fafournoux
Journal:  Nat Biotechnol       Date:  2016-06-06       Impact factor: 54.908

8.  Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus.

Authors:  David Favre; Véronique Blouin; Nathalie Provost; Radec Spisek; Françoise Porrot; Delphine Bohl; Frederic Marmé; Yan Chérel; Anna Salvetti; Bruno Hurtrel; Jean-Michel Heard; Yves Rivière; Philippe Moullier
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

9.  Separating lentiviral vector injection and induction of gene expression in time, does not prevent an immune response to rtTA in rats.

Authors:  David M Markusic; Dirk R de Waart; Jurgen Seppen
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

10.  Development of an immortalised, post-pubertal gonadotrophin-releasing hormone neuronal cell line.

Authors:  A Wolfe; Y Ng; S A Divall; S P Singh; S Radovick
Journal:  J Neuroendocrinol       Date:  2008-07-09       Impact factor: 3.627
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.